Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

More On DPH.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Dechra Pharmaceuticals plc (DPH.L)

-LSE
1,013.00 Down 12.00(1.17%) Feb 12, 11:35AM EST
Prev Close:1,025.00
Open:1,020.00
Bid:1,012.00 x 258400
Ask:1,014.00 x 9400
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1,007.00 - 1,028.00
52wk Range:860.00 - 1,110.00
Volume:74,732
Avg Vol (3m):98,825
Market Cap:891.95M
P/E (ttm):46.05
EPS (ttm):22.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.22
P/S (ttm):442.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :42.61
Quarterly EPS Est (Dec-15) :N/A
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dechra Pharmaceuticals plc develops, manufactures, sells, and markets veterinary pharmaceuticals and related products for veterinarians worldwide. It offers various dermatology and care, ophthalmology, anesthesia and analgesia, endocrinology, card... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback